Skip to main content

Advertisement

Log in

Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Generic utility measures of health-related quality of life provide an independent net valuation of health states. They are increasingly used with condition-specific outcome measures in assessing treatments. In Bipolar Disorder, a few studies indicate poorer quality of life for depressed vs. euthymic patients. A single study suggests mania is less negative than depression. This analysis examines the relationship of one such scale, the EuroQol (EQ-5D), to objective and subjective measures of depression and mania in 221 Bipolar subjects, recently or still in an episode of illness. Results: Depressed patients showed a very poor quality of life (median EQ-5D Index score 0.41). Index and Visual Analogue scores improved significantly as level of depression decreased (Jonckheere–Terpstra test p<0.001). Both scores were significantly negatively related to all depression measures. Patients reported problems across all areas of life covered by the EQ-5D. No such relationships were observed between EQ-5D scores and mania measures, though all mania measures were inter-related. However, the range of mania shown was quite restricted. Conclusions: The EQ-5D is a useful measure of quality of life for Bipolar patients suffering from depression. Conclusions about the role of the EQ-5D in mania are restricted by the limited range of mania observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ASRM:

Altman Self Rating scale for Mania

BDI:

Beck Depression Inventory

BRMS:

Bech-Rafaelsen Mania Rating Scale – Modified version

EQ-5D:

EuroQol

HRSD:

Hamilton Rating Scale for Depression

HUI:

Health Utilities Index

LIFE:

Longitudinal Interval Follow-up Evaluation

MID:

Minimally important difference

SAS:

Social Adjustment Scale

SF-20:

20-item version of Medical Outcomes Study Short Form-36

SF-36:

Medical Outcomes Study Short Form-36

VAS:

EQ-5D Visual Analogue Scale Score

References

  1. Namjoshi MA and Buesching DP (2001). A review of the health-related quality of life literature in bipolar disorder. Qual Life Res 10: 105–115

    Article  PubMed  CAS  Google Scholar 

  2. Weissman MM, Bland RC and Canino CJ (1996). Cross-national epidemiology of major depression and bipolar disorder. J Am Med Assoc 276: 293–299

    Article  CAS  Google Scholar 

  3. Bebbington P and Ramana R (1995). The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30: 279–292

    Article  PubMed  CAS  Google Scholar 

  4. Murray CJ and Lopez AD (1997). Global mortality, disability and the contribution of risk factors: Global burden of disease study. Lancet 349: 1436–1442

    Article  PubMed  CAS  Google Scholar 

  5. Das Gupta R and Guest JF (2002). Annual cost of bipolar disorder to UK society. Br J Psychiatry 180: 227–233

    Article  PubMed  Google Scholar 

  6. Goodwin FK and Jamison KR (1990). Manic-Depressive Illness. Oxford University Press, New York

    Google Scholar 

  7. National Institute for Clinical Excellence. Response to the Report of the Health Select Committee, 2002

  8. Ware JE, Snow KK and Kosinski M (1993). SF-36 Health Survey Manual and Interpretation Guide. New England Medical Center The Health Institute, Boston, MA

    Google Scholar 

  9. Hunt SM, McKenna SP and McEwen J (1993). The Nottingham Health Profile User’s Manual. Galen Research, Manchester

    Google Scholar 

  10. Torrance GW, Feeny DH and Furlong WJ (1996). Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index mark 2. Med Care 34: 702–722

    Article  PubMed  CAS  Google Scholar 

  11. (1990). EuroQol EQ-5D: A new facility for the measurement of health-related quality of life. Health Policy 19: 199–208

    Google Scholar 

  12. Brooks R, (1996). EuroQol: The current state of play. Health Policy 37: 53–72

    Article  PubMed  CAS  Google Scholar 

  13. Revicki DA, Paramore LC and Sommerville KW (2003). Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: Health related quality of life and medical cost outcomes. J Clin Psychiatry 64: 299–294

    Article  Google Scholar 

  14. Dolan P (1997). Modeling valuations for EuroQol health states. Med Care 35: 1095–1108

    Article  PubMed  CAS  Google Scholar 

  15. Efficace F, Bottomley A and Vanvoorden V (2004). Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 40: 187–197

    Article  PubMed  CAS  Google Scholar 

  16. Marra CA, Woolcott JC and Kopec JA (2005). A comparison of generic, indirect utility measures (the HU12, HU13, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQol and the HAQ) in rheumatoid arthritis. Soc Sci Med 60: 1571–1582

    Article  PubMed  Google Scholar 

  17. Herrman H, Hawthorne G and Thomas R (2002). Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol 37: 510–518

    Article  PubMed  Google Scholar 

  18. Leidy NK, Palmer C and Murray R (1998). Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures. J Affect Disord 48: 207–214

    Article  PubMed  CAS  Google Scholar 

  19. MacQueen GM, Young TL and Robb JC (1997). Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. J Affect Disord 46: 69–72

    Article  PubMed  CAS  Google Scholar 

  20. Ozer S, Ulasahin A and Batur S (2002). Outcome measures of interepisode bipolar patients in a Turkish sample. Soc Psychiatry Psychiatr Epidemiol 37: 31–37

    Article  PubMed  Google Scholar 

  21. Tsevat J, Keck PE and Hornung RW (2000). Health values of patients with bipolar disorder. Qual Life Res 9: 579–586

    Article  PubMed  CAS  Google Scholar 

  22. Vojta C, Kinosian B and Glick H (2001). Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 42: 190–195

    Article  PubMed  CAS  Google Scholar 

  23. Stewart AL, Hays RD and Ware JE (1988). The MOS short-form general health survey. Med Care 26: 724–735

    Article  PubMed  CAS  Google Scholar 

  24. Scott J, Paykel E, Morriss R, et al. Cognitive behaviour therapy for severe and recurrent bipolar disorders: a randomised controlled trial. Br J Psychiatry 2006; 188(4)

  25. Lindeboom R, Sprangers MA and Zwinderman AH (2005). Responsiveness: A reinvention of the wheel. Health Qual Life Outcomes 3: 8

    Article  PubMed  Google Scholar 

  26. Keller MB, Lavori PW and Friedman B (1987). The Longitudinal Interval Follow-up Evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 44: 540–548

    PubMed  CAS  Google Scholar 

  27. First MB, Spitzer RL and Gibbon M (1997). Structured Clinical Interview for DSM IV Axis I Disorders. American Psychiatric Press, Washington

    Google Scholar 

  28. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62

    PubMed  CAS  Google Scholar 

  29. Licht R and Jensen J (1997). Validation of the Bech-Rafaelsen scale. Acta Psychiatr Scand 96: 367–372

    PubMed  CAS  Google Scholar 

  30. Beck AT, Ward CH and Mendelson M (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571

    PubMed  CAS  Google Scholar 

  31. Altman EG, Hedecker D and Peterson JL (1997). The Altman Self-Rating Mania Scale. Biol Psychiatry 42: 948–955

    Article  PubMed  CAS  Google Scholar 

  32. Weissman MM and Paykel ES (1974). The Depressed Woman. University of Chicago Press, Chicago

    Google Scholar 

  33. Siegel S and Castellan NJ (1988). Nonparametric Statistics for the Behavioral Sciences. McGraw Hill, New York

    Google Scholar 

  34. Guyatt GH, Berman LB and Townsend M (1987). A measure of quality of life in clinical trials in chronic lung disease. Thorax 42: 773–778

    PubMed  CAS  Google Scholar 

  35. Kind P, Hardman G and Macran S (1999). UK Population Norms for EQ-5D. University of York Centre for Health Economics (Discussion paper 172), York

    Google Scholar 

  36. Tengs TO and Wallace MA (2000). One thousand health-related quality-of-life estimates. Med Care 38: 583–637

    Article  PubMed  CAS  Google Scholar 

  37. Sapin C, Fantino B and Nowicki M-L (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2: 20–27

    Article  PubMed  Google Scholar 

  38. Prieto L, Sacristan JA and Hormaechea JA (2004). Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin 20: 827–835

    Article  PubMed  CAS  Google Scholar 

  39. Orley J, Saxena S and Herrman H (1998). Quality of life and mental illness. Br J Psychiatry 172: 291–293

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hazel Hayhurst.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayhurst, H., Palmer, S., Abbott, R. et al. Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures. Qual Life Res 15, 1271–1280 (2006). https://doi.org/10.1007/s11136-006-0059-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-006-0059-z

Keywords

Navigation